Literature DB >> 24012403

Translational research in endocrine surgery.

Scott K Sherman1, James R Howe.   

Abstract

This article reviews translational research in endocrine surgery, with a focus on disorders of the thyroid, parathyroids, adrenals, and endocrine pancreas. Discovery of genes responsible for heritable endocrine cancer syndromes has increased knowledge of the causes and mechanisms of endocrine cancer and has refined surgical treatment options. Knowledge of mutations in sporadic cancer has led to rapid progress in small-molecule kinase inhibitor strategies. These breakthroughs and their influence on current therapy are discussed to provide surgeons with an overview of the basic science research currently creating new clinical treatments and improving patient care.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Endocrine cancer; Heritable cancer syndromes; MEN2; Pancreatic neuroendocrine tumors; Thyroid surgery

Mesh：

Year:  2013        PMID： 24012403      PMCID： PMC3794713          DOI： 10.1016/j.soc.2013.06.012

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN： 1055-3207            Impact factor:   3.495


  162 in total

1.  Gastric inhibitory polypeptide-dependent cortisol hypersecretion--a new cause of Cushing's syndrome.

Authors:  A Lacroix; E Bolté; J Tremblay; J Dupré; P Poitras; H Fournier; J Garon; D Garrel; F Bayard; R Taillefer
Journal:  N Engl J Med       Date:  1992-10-01       Impact factor: 91.245

2.  Gene expression profiling of human adrenocortical tumors using complementary deoxyribonucleic Acid microarrays identifies several candidate genes as markers of malignancy.

Authors:  Florence de Fraipont; Michelle El Atifi; Nadia Cherradi; Gwennaelle Le Moigne; Geneviève Defaye; Rémi Houlgatte; Jérôme Bertherat; Xavier Bertagna; Pierre-François Plouin; Eric Baudin; François Berger; Christine Gicquel; Olivier Chabre; Jean-Jacques Feige
Journal:  J Clin Endocrinol Metab       Date:  2004-12-21       Impact factor: 5.958

3.  Activation of a novel human transforming gene, ret, by DNA rearrangement.

Authors:  M Takahashi; J Ritz; G M Cooper
Journal:  Cell       Date:  1985-09       Impact factor: 41.582

4.  Suppression of pancreatic endocrine tumour secretion by long-acting somatostatin analogue.

Authors:  R G Long; A J Barnes; T E Adrian; C N Mallinson; M R Brown; W Vale; J E Rivier; N D Christofides; S R Bloom
Journal:  Lancet       Date:  1979-10-13       Impact factor: 79.321

5.  The NF1 tumor suppressor critically regulates TSC2 and mTOR.

Authors:  Cory M Johannessen; Elizabeth E Reczek; Marianne F James; Hilde Brems; Eric Legius; Karen Cichowski
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-03       Impact factor: 11.205

Review 6.  Alternative lengthening of telomeres in mammalian cells.

Authors:  Jeremy D Henson; Axel A Neumann; Thomas R Yeager; Roger R Reddel
Journal:  Oncogene       Date:  2002-01-21       Impact factor: 9.867

7.  Sunitinib malate for the treatment of pancreatic neuroendocrine tumors.

Authors:  Eric Raymond; Laetitia Dahan; Jean-Luc Raoul; Yung-Jue Bang; Ivan Borbath; Catherine Lombard-Bohas; Juan Valle; Peter Metrakos; Denis Smith; Aaron Vinik; Jen-Shi Chen; Dieter Hörsch; Pascal Hammel; Bertram Wiedenmann; Eric Van Cutsem; Shem Patyna; Dongrui Ray Lu; Carolyn Blanckmeister; Richard Chao; Philippe Ruszniewski
Journal:  N Engl J Med       Date:  2011-02-10       Impact factor: 91.245

8.  K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension.

Authors:  Murim Choi; Ute I Scholl; Peng Yue; Peyman Björklund; Bixiao Zhao; Carol Nelson-Williams; Weizhen Ji; Yoonsang Cho; Aniruddh Patel; Clara J Men; Elias Lolis; Max V Wisgerhof; David S Geller; Shrikant Mane; Per Hellman; Gunnar Westin; Göran Åkerström; Wenhui Wang; Tobias Carling; Richard P Lifton
Journal:  Science       Date:  2011-02-11       Impact factor: 47.728

Review 9.  BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications.

Authors:  Mingzhao Xing
Journal:  Endocr Rev       Date:  2007-10-16       Impact factor: 19.871

10.  A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases.

Authors:  A Fusco; M Grieco; M Santoro; M T Berlingieri; S Pilotti; M A Pierotti; G Della Porta; G Vecchio
Journal:  Nature       Date:  1987 Jul 9-15       Impact factor: 49.962
View more
  10 in total

1.  GIPR expression in gastric and duodenal neuroendocrine tumors.

Authors:  Scott K Sherman; Jessica E Maxwell; Jennifer C Carr; Donghong Wang; M Sue O'Dorisio; Thomas M O'Dorisio; James R Howe
Journal:  J Surg Res       Date:  2014-01-29       Impact factor: 2.192

2.  RABL6A promotes G1-S phase progression and pancreatic neuroendocrine tumor cell proliferation in an Rb1-dependent manner.

Authors:  Jussara Hagen; Viviane P Muniz; Kelly C Falls; Sara M Reed; Agshin F Taghiyev; Frederick W Quelle; Francoise A Gourronc; Aloysius J Klingelhutz; Heather J Major; Ryan W Askeland; Scott K Sherman; Thomas M O'Dorisio; Andrew M Bellizzi; James R Howe; Benjamin W Darbro; Dawn E Quelle
Journal:  Cancer Res       Date:  2014-10-01       Impact factor: 12.701

Review 3.  Translational Diagnostics and Therapeutics in Pancreatic Neuroendocrine Tumors.

Authors:  Jessica E Maxwell; Scott K Sherman; James R Howe
Journal:  Clin Cancer Res       Date:  2016-10-15       Impact factor: 12.531

4.  Small Bowel Neuroendocrine Tumors.

Authors:  Catherine G Tran; Scott K Sherman; James R Howe
Journal:  Curr Probl Surg       Date:  2020-05-15       Impact factor: 1.909

5.  RABL6A inhibits tumor-suppressive PP2A/AKT signaling to drive pancreatic neuroendocrine tumor growth.

Authors:  Shaikamjad Umesalma; Courtney A Kaemmer; Jordan L Kohlmeyer; Blake Letney; Angela M Schab; Jacqueline A Reilly; Ryan M Sheehy; Jussara Hagen; Nitija Tiwari; Fenghuang Zhan; Mariah R Leidinger; Thomas M O'Dorisio; Joseph Dillon; Ronald A Merrill; David K Meyerholz; Abbey L Perl; Bart J Brown; Terry A Braun; Aaron T Scott; Timothy Ginader; Agshin F Taghiyev; Gideon K Zamba; James R Howe; Stefan Strack; Andrew M Bellizzi; Goutham Narla; Benjamin W Darbro; Frederick W Quelle; Dawn E Quelle
Journal:  J Clin Invest       Date:  2019-03-04       Impact factor: 14.808

6.  Gene expression accurately distinguishes liver metastases of small bowel and pancreas neuroendocrine tumors.

Authors:  Scott K Sherman; Jessica E Maxwell; Jennifer C Carr; Donghong Wang; Andrew M Bellizzi; M Sue O'Dorisio; Thomas M O'Dorisio; James R Howe
Journal:  Clin Exp Metastasis       Date:  2014-09-21       Impact factor: 5.150

Review 7.  Medical management of metastatic medullary thyroid cancer.

Authors:  Jessica E Maxwell; Scott K Sherman; Thomas M O'Dorisio; James R Howe
Journal:  Cancer       Date:  2014-06-18       Impact factor: 6.860

Review 8.  The Landmark Series: Management of Small Bowel Neuroendocrine Tumors.

Authors:  Catherine G Tran; Scott K Sherman; James R Howe
Journal:  Ann Surg Oncol       Date:  2021-01-15       Impact factor: 5.344

9.  Development and comparison of novel bioluminescent mouse models of pancreatic neuroendocrine neoplasm metastasis.

Authors:  Courtney A Kaemmer; Shaikamjad Umesalma; Chandra K Maharjan; Devon L Moose; Goutham Narla; Sarah L Mott; Gideon K D Zamba; Patrick Breheny; Benjamin W Darbro; Andrew M Bellizzi; Michael D Henry; Dawn E Quelle
Journal:  Sci Rep       Date:  2021-05-13       Impact factor: 4.379

Review 10.  Surgical Management of Neuroendocrine Tumor Liver Metastases.

Authors:  Catherine G Tran; Scott K Sherman; Chandrikha Chandrasekharan; James R Howe
Journal:  Surg Oncol Clin N Am       Date:  2020-10-20       Impact factor: 3.495
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.